MILWAUKEE, WI / ACCESS Newswire / June 5, 2025 / Diversatek Healthcare is excited to announce the release of Zvu® 3.4.0, the latest software version now fully compatible with the Chicago ...

Terrance Cole, the nominee for Administrator of the U.S. Drug Enforcement Administration (DEA), stands at a pivotal juncture with the opportunity to address longstanding issues related to the agency's ...

Survey Highlights Immediate Steps Needed for Health Systems to Ensure Readiness, Cybersecurity, and Operational Preparedness NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Hospitals and ...

MILWAUKEE, WISCONSIN / ACCESS Newswire / June 5, 2025 / Serve You Rx announced today that its Biosimilar Advantage Formulary now includes two newly approved biosimilars to Stelara® (ustekinumab): ...

Latest update includes new, improved tools for more precise tumor assessment and stroke care. AARHUS, DENMARK / ACCESS Newswire / June 5, 2025 / Cercare Medical, a leader in advanced neuroimaging ...

Travel Nurses, Inc. announced Alexis Ray, RN from Sturgis, Mississippi, as their second quarter DAISY Award honoree for 2025. GERMANTOWN, TN / ACCESS Newswire / June 5, 2025 / Travel Nurses, Inc.

TURKU, FI / ACCESS Newswire / June 5, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN)(AIM:FARN)(First North:FARON), a clinical-stage biopharmaceutical company focused on developing novel ...

The 2025 report, commissioned by the Alliance for International Exchange, provides further evidence of the key cultural and financial benefits of au pair programs for American families NEW YORK CITY, ...

Hospitals equipped for surge in summer births with on-demand Labor & Delivery and NICU rentals from US Med-Equip HOUSTON, TX / ACCESS Newswire / June 5, 2025 / As hospitals across the United States ...

Three shots. Three Months. Done. COLUMBUS, OH / ACCESS Newswire / June 5, 2025 / Premier Allergy & Asthma, a leading allergy and immunology clinic in Central Ohio, is proud to announce the launch of ...

AM ET to discuss Company's lead program, TPI 287, in development for treatment of glioblastoma multiforme (GBM) HOUSTON, TX / ACCESS Newswire / June 5, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ( ...

The global contrast media APIs market is set to witness a growth rate of 5% in the next 5 years. Rising volume of diagnostic ...